When SS1 and SS2, as well as serum PON-1 and ARE activities, were compared between the patients with CS and without CS, the SS1 and the SS2 scores were calculated to be significantly greater in the patients with CS (P=0.044 and P<0.001, respectively). This evidence concerns the gene PON1 and Cowden syndrome 1.